Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Kesteven

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Lancet (London, England)|March 12, 1999
Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complicationsG P Aithal, C P Day, P J Kesteven, et al.
Clinical and Laboratory Haematology|January 1, 1985
Hypersplenism and splenectomy in lymphoproliferative and myeloproliferative disordersP J Kesteven, J M Pullan, U H Glass, et al.
Clinical Otolaryngology and Allied Sciences|October 1, 1995
Do patients with epistaxis have drug-induced platelet dysfunction?J R Livesey, M G Watson, P J Kelly, et al.
Thrombosis and Haemostasis|October 31, 1983
Rapid quantitation of plasma heparin and antithrombin III levels for cardiopulmonary bypass monitoring, using fluorometric substrate assaysG F Savidge, P J Kesteven, S F Al-Hasani, et al.
The Journal of Cardiovascular Surgery|September 1, 1986
Protamine sulphate and heparin rebound following open-heart surgeryP J Kesteven, A Ahmed, C Aps, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 13, 2011
Impact of biomarkers for endothelial dysfunction and procoagulant state on 10-year cardiovascular risk in Type 2 diabetesA Natarajan, S M Marshall, P J Kesteven, et al.
Intensive Care Medicine|January 1, 1990
Disseminated zygomycosis and systemic lupus erythematosusC A Bloxham, S Carr, D W Ryan, et al.
British Heart Journal|October 1, 1995
Rescue thrombolysis: alteplase as adjuvant treatment after streptokinase in acute myocardial infarctionJ P Mounsey, J S Skinner, T Hawkins, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Lancet (London, England)|March 12, 1999
Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complicationsG P Aithal, C P Day, P J Kesteven, et al.
Clinical and Laboratory Haematology|January 1, 1985
Hypersplenism and splenectomy in lymphoproliferative and myeloproliferative disordersP J Kesteven, J M Pullan, U H Glass, et al.
Clinical Otolaryngology and Allied Sciences|October 1, 1995
Do patients with epistaxis have drug-induced platelet dysfunction?J R Livesey, M G Watson, P J Kelly, et al.
Thrombosis and Haemostasis|October 31, 1983
Rapid quantitation of plasma heparin and antithrombin III levels for cardiopulmonary bypass monitoring, using fluorometric substrate assaysG F Savidge, P J Kesteven, S F Al-Hasani, et al.
The Journal of Cardiovascular Surgery|September 1, 1986
Protamine sulphate and heparin rebound following open-heart surgeryP J Kesteven, A Ahmed, C Aps, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 13, 2011
Impact of biomarkers for endothelial dysfunction and procoagulant state on 10-year cardiovascular risk in Type 2 diabetesA Natarajan, S M Marshall, P J Kesteven, et al.
Intensive Care Medicine|January 1, 1990
Disseminated zygomycosis and systemic lupus erythematosusC A Bloxham, S Carr, D W Ryan, et al.
British Heart Journal|October 1, 1995
Rescue thrombolysis: alteplase as adjuvant treatment after streptokinase in acute myocardial infarctionJ P Mounsey, J S Skinner, T Hawkins, et al.
Pageof 2